Journey Medical Corp (NASDAQ:DERM) shares, rose in value on Thursday, April 16, with the stock price up by 0.64% to the previous day’s close as strong demand from buyers drove the stock to $6.25.
Actively observing the price movement in the last trading, the stock closed the session at $6.21, falling within a range of $6.05 and $6.3. The value of beta (5-year monthly) was 0.907. Referring to stock’s 52-week performance, its high was $7.29, and the low was $3.20. On the whole, DERM has fluctuated by 8.70% over the past month.
With the market capitalization of Journey Medical Corp currently standing at about $144.40 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-25.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 71.45M, with a low estimate of 10.39M and a high estimate of 13.38M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 12.05M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that DERM’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of DERM currently trading nearly -0.29% and 10.50% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 53.66, while the 7-day volatility ratio is showing 6.06% which for the 30-day chart, stands at 10.19%. Furthermore, Journey Medical Corp (DERM)’s beta value is 0.84, and its average true range (ATR) is 0.53.
A comparison of Journey Medical Corp (DERM) with its peers suggests the former has fared considerably weaker in the market. DERM showed an intraday change of 0.64% in last session, and over the past year, it grew by 64.47%%.
Data on historical trading for Journey Medical Corp (NASDAQ:DERM) indicates that the trading volumes over the past 10 days have averaged 0.12 and over the past 3 months, they’ve averaged 69.60K. According to company’s latest data on outstanding shares, there are 16.15 million shares outstanding.
Nearly 59.06% of Journey Medical Corp’s shares belong to company insiders and institutional investors own 16.36% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.15 million shares as on 2025-03-31, resulting in a short ratio of 2.31. According to the data, the short interest in Journey Medical Corp (DERM) stood at 224.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 0.11 million. The stock has risen by 59.85% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the DERM stock heading into the next quarter.
